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16 Abstract 
 
 
17 Dietary  restriction  (DR)  extends  lifespan  and  healthspan  in  many  species,  but 
 
18 precisely how it elicits its beneficial effects is unclear. We investigated the impact of 
 
19 DR on mitochondrial function within liver and skeletal muscle of female ILSXISS 
 
20 mice that exhibit strain-specific variation in lifespan under 40% DR. Strains TejJ89 
 
21 (lifespan increased under DR), TejJ48 (lifespan unaffected by DR) and TejJ114 
 
22 (lifespan decreased under DR) were studied following 10 months of 40% DR (13 
 
23 months of age). Oxygen consumption rates (OCR) within isolated liver mitochondria 
 
24 were unaffected by DR in TejJ89 and TejJ48, but decreased by DR in TejJ114. DR 
 
25 had no effect on hepatic protein levels of PGC-1a, TFAM, and OXPHOS complexes 
 
26 I-V. Mitonuclear protein imbalance (nDNA:mtDNA ratio) was unaffected by DR, but 
 
27 HSP90  protein  levels  were  reduced  in  TejJ114  under  DR.  Surprisingly  hepatic 
 
28 mitochondrial hydrogen peroxide (H2O2) production was elevated by DR in TejJ89, 
 
29 with total superoxide dismutase activity and protein carbonyls increased by DR in 
 
30 both TejJ89 and TejJ114. In skeletal muscle, DR had no effect on mitochondrial 
 
31 OCR, OXPHOS complexes or mitonuclear protein imbalance, but H2O2  production 
 
32 was decreased in TejJ114 and nuclear PGC-1a increased in TejJ89 under DR. Our 
 
33 findings  indicate  that  hepatic  mitochondrial  dysfunction  associates  with  reduced 
 
34 lifespan of TejJ114 mice under 40% DR, but similar dysfunction is not seen in 
 
35 skeletal  muscle  mitochondria.  We  highlight  tissue-specific  differences  in  the 
 
36 mitochondrial response in ILSXISS mice to DR, and underline the importance and 
 
37 challenges of exploiting genetic heterogeneity to help understand mechanisms of 
 
38 ageing. 
 
39 
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42 1.1 Introduction 
 
 
43 Dietary restriction (DR), in its most general sense; defined here as reductions 
 
44 in energy intake, reductions in specific macro or micronutrients or as intermittent 
 
45 fasting,  is  the  most  extensively  applied  experimental  intervention  employed  to 
 
46 manipulate ageing and longevity [1], [2]. Since the first study demonstrating that DR 
 
47 extended the reproductive period and lifespan of female rats almost one century ago 
 
48 [3], an extensive body of research has studied the effects of DR in a wide number of 
 
49 organisms (reviewed in [1], [2], [4]–[6]). In addition to its effects on lifespan, DR also 
 
50 attenuates  and/or  postpones  a  broad-spectrum  of  age-associated  pathologies, 
 
51 including obesity, insulin resistance, cognitive decline, immune dysfunction, stem cell 
 
52 ageing, sarcopaenia and cataracts [1], [2], [4], [5]. DR in rodents confers protection 
 
53 against  a  number  of  spontaneous  and  experimentally-induced  cancers  [6],  and 
 
54 delays several age-associated pathologies, including metabolic and cardiovascular 
 
55 disease, cancer and brain atrophy in non-human primates [7]–[9]. Similarly, DR 
 
56 elicits numerous beneficial metabolic effects in humans including weight loss, lower 
 
57 visceral and intramuscular adiposity, insulin sensitivity and lowers several risk factors 
 
58 linked to cancer and cardiovascular disease [10], [11]. 
 
 
59 However, contrary to the belief that the effect of DR on longevity is universal, 
 
60 several studies have reported a lack of, or even a detrimental effect of, DR on 
 
61 lifespan [9], [12]–[16] (reviewed in [17]). In Rhesus macaques (Macaca mulatta), DR 
 
62 extended lifespan in a study conducted by the National Primate Research Center at 
 
63 the University of Wisconsin [7], but did not extend lifespan in a study undertaken by 
 
64 the National Institute of Health [9]. The precise reasons for the differing outcomes 
 
65 between these studies appears complex but may reflect inter-study differences in 
 
66 diet, animal husbandry and geographical origin [1], [7], [18]. In addition, a potentially 
67 critical factor that may help explain the unresponsiveness of particular organisms to 
 
68 DR-induced longevity is genetic background [1], [7], [18], [19]. For example, the 
 
69 effect of DR on survival in DBA/2 mice has been a source of debate for many years, 
 
70 with DR reported to extend [20], [21], have no effect [22], or shorten lifespan [14]. 
 
71 However, a recent study examining lifespan in male and female DBA/2 and C57BL/6 
 
72 mice under 20% and 40% DR revealed that DBA/2 mice are indeed responsive to 
 
73 DR, although the impact of sex, strain and the magnitude of DR on survival outcome 
 
74 appears important [23]. In two independent studies undertaken by the Universities of 
 
75 Texas  [24]  and  Colorado  [15],  survival  was  determined  in  multiple  strains  of 
 
76 heterogeneous  ILSXISS  recombinant  inbred  mice  maintained  on  40%  DR,  with 
 
77 distinct strain-specific effects on survival observed following 40% DR. The first study 
 
78 [24] reported that across 39 female and 41 male strains studied, only 21% of female 
 
79 strains showed life extension under DR, and only 5% of male strains. Surprisingly, a 
 
80 greater  number  of  strains  (27%  and  26%  for  females  and  males  respectively) 
 
81 showed reduced lifespan under DR. The latter study [15], which assayed 42 female 
 
82 ILSXISS strains, similarly reported a significant strain-specific response to DR, with 
 
83 only 21% of strains showing life extension and 19% showing life shortening effects of 
 
84 DR. 
 
 
85 Despite  DR  being  the  primary  experimental intervention  used  to  study 
 
86 ageing, it is still unclear as to precisely how DR acts mechanistically to induce its 
 
87 effects, although a multitude of mechanisms have been proposed [4], [5], [25]–[27]. 
 
88 Mitochondrial dysfunction is a key hallmark of ageing and disease [28], with ageing 
 
89 associated with altered mitochondrial morphology, reduced mitochondrial oxidative 
 
90 capacity  and  ATP  production,  increased  mitochondrial-derived  reactive  oxygen 
 
91 species  (ROS)  generation  and  greater  oxidative  damage  [29].  Consequently, 
92 significant research effort has investigated whether DR can induce beneficial effects 
 
93 on the mitochondrial phenotype, such as maintaining mitochondrial function during 
 
94 ageing, reducing ROS production and  attenuating oxidative  damage. While  it is 
 
95 generally  assumed  that  DR  reduces  ROS  production,  a  recent  meta-analysis 
 
96 involving 157 rodent DR studies in which ROS levels (primarily hydrogen peroxide) 
 
97 were assayed, highlighted that 62% of studies actually reported no change in ROS 
 
98 levels relative to ad libitum (AL) fed controls [30]. Ambiguity also exists regarding the 
 
99 effect of DR on mitochondrial respiration in rodents, with DR reported to increase 
 
100 [31]–[34], decrease [35], or have no effect relative to AL controls [36]. Similarly, the 
 
101 impact of DR on various antioxidants and markers of oxidative damage appears 
 
102 fairly inconclusive, although as with all these parameters tissue-specific effects, the 
 
103 duration and intensity of DR, the sex and the age of the animals at the point of study 
 
104 may affect experimental outcomes [30]. The concept that DR induces mitochondrial 
 
105 biogenesis, that is the production of new mitochondrial proteins, has been proposed 
 
106 as a critical mechanism underlying the beneficial effects of DR [37], with DR reported 
 
107 to  induce  mitochondrial  biogenesis  in  a  number  of  tissues  including  liver  [33]. 
 
108 Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) is 
 
109 described as the master regulator of mitochondrial biogenesis [38]. DR slows age- 
 
110 related declines in Pgc-1α expression in rat skeletal muscle and heart, and it is 
 
111 proposed that mitochondrial function adapts to DR through PGC1α regulation [33], 
 
112 [39], [40]. However, there is considerable debate in the literature as to how best to 
 
113 quantify  biogenesis.  Indeed,  several  studies  suggest  that  DR  may  increase 
 
114 mitochondrial efficiency in order to maintain an ‘optimally efficient’ electron transport 
 
115 system, potentially driven by the nuclear localisation of PGC1-α [39], [41] without any 
 
116 increase in mitochondrial number per se [31], [34], [42]. Hancock et al [42] examined 
117 a range of tissues, including liver and skeletal muscle, in rats and suggested that 
 
118 rather than altering rate of protein synthesis in the mitochondria that DR affords 
 
119 protection to mitochondria through defending against DNA damage. Similarly, Lanza 
 
120 et al [34] reported that DR did not stimulate the synthesis of new mitochondrial 
 
121 proteins in mouse skeletal muscle, but rather minimised damage to existing cellular 
 
122 components, through decreased mitochondrial oxidant emission and upregulated 
 
123 antioxidant defences. Indeed, mitochondrial protein synthesis within liver, muscle 
 
124 and  heart  of  mice  was  unaffected  by  DR,  although  cellular  proliferation  was 
 
125 decreased  [43],  with  a  recent  proteomic  approach  reporting  that  mitochondrial 
 
126 biogenesis may actually be reduced within liver of DR mice [44]. Consequently, such 
 
127 findings  question  the  concept  that  DR  increases  mitochondrial  biogenesis,  and 
 
128 further challenge the somewhat counterintuitive idea of expending energy on protein 
 
129 synthesis at a time of energy and/or nutrient restriction [34]. 
 
 
130 Recently, the role of mitonuclear protein imbalance, that is a stoichiometric 
 
131 imbalance  between  OXPHOS  subunits  encoded  by  nuclear  DNA  (nDNA)  and 
 
132 
 
133 
mitochondrial  DNA  (mtDNA)  which  activates  the  cytoprotective  mitochondrial 
 
unfolded  protein  response  (UPRmt),  in  longevity  control  has  gained  significant 
 
134 
 
135 
coverage (see[45]–[48]). Both rapamycin and resveratrol induced mitonuclear protein 
 
imbalance and UPRmt  in mouse hepatocytes in vitro [45]. UPRmt  induction in C. 
 
136 elegans also appeared necessary for longevity in developing worms exposed to high 
 
137 glucose, but shortened lifespan when induced in adulthood [49]. Longevity in BXD 
 
138 mice is associated with reduced mitochondrial translation as determined by reduced 
 
139 expression of mitochondrial protein 5 (Mrps-5); Mrps-5 expression in skeletal muscle 
 
140 
 
141 
decreases with age and this is attenuated by DR [45]. In addition, skeletal muscle 
from  long-lived  Surf1-/-   mice  display  evidence  of  UPRmt  [50].  However,  whether 
 142 mitonuclear imbalance and UPR
mt  are important in DR-induced longevity in mice 
 
143 remains to be elucidated. 
 
 
144 Given the ongoing quest to identify the mechanistic drivers of DR, it has been 
 
145 suggested that employing a comparative-type approach which takes advantage of 
 
146 the  variability  in  the  DR  response  reported  in  certain  rodent  strains  may  help 
 
147 delineate the mechanisms underpinning DR [17], [19]. Indeed, several groups have 
 
148 already  undertaken  such  approaches  using  DBA/2  mice  [51]–[53],  showing  for 
 
149 example that this strain are hyperinsulinaemic and insulin resistant compared to 
 
150 C57BL/6  mice  [54].  In  the  present  study  we  investigated  the  potential  linkage 
 
151 between  DR-induced  longevity  and  mitochondrial  function  within  both  liver  and 
 
152 skeletal muscle by exploiting the highly variable effect of DR on lifespan in ILSXISS 
 
153 mice. To this end we compared females mice from three ILSXISS strains showing 
 
154 repeatable  responses  to  DR  across  two  independent  studies  [15],  [24];  TejJ89 
 
155 (lifespan extended under DR relative to AL controls), TejJ48 (lifespan unaffected by 
 
156 DR),  and TejJ114  (lifespan  shortened  under DR). We  predicted  that  DR  would 
 
157 positively impact on a number of parameters associated with mitochondrial function 
 
158 in strain TejJ89, that DR would have no impact on these parameters in strain TejJ48, 
 
159 and that DR would induce mitochondrial dysfunction in the negative responding 
 
160 
 
 
161 
TejJ114 (see Figure 1 for schematic outlining our original predictions). 
162 2. Materials and methods 
 
 
163 Animals 
 
 
164 ILSXISS  recombinant  inbred  (RI)  mouse  strains  are  derived  from  a  cross 
 
165 between inbred long sleep (ILS) and inbred short sleep (ISS) mice [55]. Mice from 
 
166 three  strains;  TejJ89,  TejJ48  and  TejJ114  were  purchased  from  a  commercial 
 
167 breeder (The Jackson Laboratory, Bar Harbour, Maine, URL: 
 
168 http://www.informatics.jax.org).  The  rationale  for  studying  these  particular  strains 
 
169 was that in addition to repeatable effect of DR on lifespan across two independent 
 
170 studies [15], [24], no strain-specific differences in median lifespan were observed 
 
171 upon ad libitum (AL) feeding. Mice were maintained in groups of 4 post-weaning in 
 
172 shoebox cages (48cm×15cm×13cm), with AL access to water and standard chow 
 
173 (CRM(P), Research Diets Services, LBS Biotech, UK; Atwater Fuel Energy- protein 
 
174 22%, carbohydrate 69%, fat 9%) and maintained on a 12L/12D cycle (lights on 
 
175 0700–1900h) at 22±2°C. At 9 weeks of age, cages were assigned to either an AL or 
 
176 DR group, with no difference in body mass observed between treatment groups at 
 
177 this time (TejJ89 AL vs. DR t=0.056, p=0.583, TejJ48 AL vs. DR t=0.677, p=0.509, 
 
178 TejJ114 AL vs. DR t=0.289, p=0.777). Mice were introduced to DR in a graded 
 
179 fashion; at 10 weeks of age mice were exposed to 10% DR (90% of AL feeding), at 
 
180 11 weeks this was increased to 20% DR, and from 12 weeks of age until the 
 
181 termination  of  the  experiment  mice  were  exposed  to  40%  DR,  relative  to  their 
 
182 appropriate strain-specific AL controls. Total food intake of AL mice from each strain 
 
183 was measured weekly (±0.01g) and food intake of the DR cohort calculated from the 
 
184 average AL intake per mouse over the preceding week [54]. DR mice were fed daily 
 
185 at  1800hrs  and  fed  directly  into  the  cage.  Following  10  months  of  40%  DR 
 
186 (equivalent to 13 months of age), mice were fasted overnight and then culled the 
187 following  morning  by  cervical  dislocation.  One  lobe  of  liver,  one  gastrocnemius 
 
188 muscle and the heart were dissected out and immediately snap-frozen in liquid 
 
189 nitrogen and stored at -80°C until use. The remaining liver tissue and gastrocnemius 
 
190 muscle were subsequently used for the mitochondrial functional studies. A total of 4 
 
191 mice per day were culled, with the time between dissection, mitochondrial isolation 
 
192 and mitochondrial analysis kept as uniformed as possible, with the particular tissue 
 
193 (liver  or  skeletal  muscle)  processed  and  analysed  alternated  each  day.  All 
 
194 experiments were carried out under a licence from the UK Home Office (Project 
 
195 Licence  60/4504)  and  followed  the  “principles  of  laboratory  animal  care”  (NIH 
 
196 Publication No. 86-23, revised 1985). 
 
 
197 Mitochondrial Respiration 
 
 
198 Isolation of Mouse Liver and Skeletal Muscle Mitochondria 
 
199 Liver mitochondria were isolated using previously published protocols [56], 
 
200 [57]. Briefly the liver was  weighed  and washed  in  MSHE+BSA buffer (210 mM 
 
201 mannitol, 70 mM sucrose, 5 mM HEPES, 1 mM EGTA and 0.5% (w/v) fatty acid free 
 
202 bovine serum albumin (pH 7.2)). The liver was rapidly minced with scissors in 10 
 
203 volumes of MSHE+BSA buffer before homogenisation (2-3 strokes) using a glass- 
 
204 glass  homogeniser  (Fisher  Scientific,  Loughborough,  UK).  As  with  the  liver, 
 
205 gastrocnemius muscle was harvested, weighed, washed and then minced in ice-cold 
 
206 isolation buffer (100 mM sucrose, 100mM KCL, 50mM Tris HCl, 1mM KH2PO4, 
 
207 0.1mM EGTA, 0.2% BSA (pH 7.4)), as set out in protocols previously described [58]. 
 
208 The muscle was subsequently rinsed three times in 1ml of fresh isolation buffer, and 
 
209 
 
210 
then 1ml of 2% Proteinase Type XXIV (Sigma Aldrich, Dorset, UK) was added and 
 
the sample vortexed for 1 min-1 at room temperature, followed by 1 min-1 incubation 
 
211 on ice. Samples were  subsequently added  to a  glass homogeniser and 4ml of 
212 isolation  buffer  added  before  homogenisation  (10  strokes).  Using  differential 
 
213 centrifugation for both liver [56] and muscle [58] a mitochondrial pellet was isolated 
 
214 and subsequently re-suspended (liver; MSHE buffer with no BSA, skeletal muscle; 
 
215 suspension buffer (225mM Mannitol, 75mM sucrose, 10mM Tris, 0.1mM EDTA (pH 
 
216 7.4)). Total liver and skeletal muscle mitochondrial protein (mg/ml) were determined 
 
217 using the Bradford assay (Sigma Aldrich, Dorset, UK). 
 
 
218 XF Assay – Plate Preparation 
 
 
219 Isolated mitochondria were diluted 10X in mitochondrial assay solution (MAS; 
 
220 70 mM sucrose, 220 mM mannitol, 10 mM KH2PO4, 5 mM MgCl2, 2 mM HEPES, 1.0 
 
221 mM EGTA and 0.2% (w/v) fatty acid-free BSA, pH 7.2) containing substrate (10 mM 
 
222 pyruvate, 2 mM malate), and subsequently diluted to produce a 10µg mitochondrial 
 
223 suspension. Mitochondria were added to wells of a Seahorse XF assay plate (Agilent 
 
224 Technologies,  CA,  USA)  at  a  concentration  of  10µg  per  well.  The  plate  was 
 
225 centrifuged at 2000g for 20 minutes at 4°C. A XF cartridge (Agilent Technologies) 
 
226 was then prepared as described by Brand et al. [56]. The plate was then transferred 
 
227 to a XF24 Analyser (Agilent Technologies) and the experiment initiated as previously 
 
228 described [57]. Basal Oxygen consumption rate (OCR) was measured in substrate 
 
229 (10 mM pyruvate, 2 µM malate). Following this OCR was sequentially recorded for 
 
230 state 3 (addition of ADP (4mM)), state 4 (addition of oligomycin (2.5 µg/ml)), state 3u 
 
231 (FCCP (4µM Carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone)), and finally in 
 
232 the presence of Antimycin A and rotenone (40µM), inhibitors of Complex III  and I 
 
233 respectively,  to  determine  non-mitochondrial  respiratory  capacity  [57].  Analysis  was 
 
234 carried out using Seahorse XF software (www.seahorsebio.com). Respiratory control 
 
235 ratio, expressed as the ratio between state 3u (FCCP-induced maximal uncoupled- 
 
236 stimulated respiration) and state 4o (respiration in the absence of ADP) did not differ 
237 by treatment within a strain or between strains for either liver or muscle mitochondria 
 
238 (Fig. S1A&B). 
 
 
239 Protein extraction 
 
 
240 Liver, skeletal muscle and heart tissue were suspended in 1ml of ice cold 
 
241 RIPA buffer (Radio Immuno Precipitation Assay buffer, 150 mM sodium chloride, 
 
242 1.0% NP-40 or Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS (sodium dodecyl 
 
243 sulphate), 50 mM Tris, pH 8.0) containing protease inhibitors (Halt™ Protease and 
 
244 Phosphatase Inhibitor Cocktail, Thermo Fisher Scientific, UK). The liver and heart 
 
245 were rapidly minced on ice with scissors and homogenised. A stainless steel bead 
 
246 (Catalogue  #  69989,  QIAGEN,  Manchester,  UK),  was  added  to  the  eppendorf 
 
247 
 
248 
containing the skeletal muscle tissue and RIPA buffer, and then homogenised at 
 
maximum speed (30Hz) for 4 min-1 on the RETSCH MM 400 mixer mill (Catalogue# 
 
249 
 
250 
10573034, Fisher Scientific). Following homogenisation all lysates were incubated 
 
on ice for 40-60 min-1 before being centrifuged at 16,000 x g for 10 min-1 at 4°C, and 
 
251 total  protein  levels  subsequently  determined  using  the  BCA  protein  assay  (G 
 
252 Biosciences, MO, USA). Nuclear and cytoplasmic fractionation of liver and skeletal 
 
253 muscle was undertaken using the ReadyPrep™ Protein Extraction 
 
254 (Cytoplasmic/Nuclear) Kit (Catalogue #163-2089, Bio-Rad, UK). Briefly, ~50 mg of 
 
255 tissue was homogenised together with 0.75ml of cold cytoplasmic protein extraction 
 
256 buffer containing protease  inhibitors (Halt™ Protease and  Phosphatase  Inhibitor 
 
257 Cocktail,) using a chilled Wheaton Dounce tissue homogeniser (Catalogue #62400- 
 
258 595, VWR, West Sussex, UK), with protein concentration of each fraction determined 
 
259 using the BCA protein assay. 
 
 
260 Western Blot Analysis 
261 Equal volumes of tissue protein extract (50μg) in Laemmli sample buffer were 
 
262 loaded  onto  4-12%  Bis-Tris  pre-cast  polyacrylamide  gels  (Life  Technologies, 
 
263 Paisley, UK). Following this, proteins were transferred to polyvinylidene difluoride 
 
264 membranes  (BioRad).  Ponceau  staining  was  used  to  ensure  equal  loading  of 
 
265 
 
266 
 
267 
 
268 
protein and for normalisation purposes. Membranes were incubated in Tris-buffered 
saline Tween (1X TBST) containing 5% BSA for 1h-1. Blots were then washed in 
TBST (5×5min), incubated with primary antibody for 24h-1  (4°C), washed again 
(TBST) and incubated with secondary antibody for 1h-1 at room temperature. Blots 
 
269 were visualised using Clarity™ Western ECL Substrate (BioRad) and a 
 
270 ChemiDoc™XRS system (BioRad). Antibodies for peroxisome proliferator-activated 
 
271 receptor-gamma co-activator 1 alpha (PGC-1α) and the oxidative phosphorylation 
 
272 complex antibody (OXPHOS cocktail; CI subunit NDUFB8, CII-30kDa (SDH), CIII- 
 
273 Core protein 2 (UQCRC2), CIV subunit I (MTCO1) and CV alpha subunit (ATP5A) 
 
274 were from Abcam, Cambridge, UK, mitochondrial transcription factor A (TFAM) and 
 
275 secondary (anti-rabbit) antibodies from Santa Cruz Biotechnology Inc. (Santa Cruz, 
 
276 CA, USA), and HSP60 and HSP90 from BD Biosciences (BD Biosciences, Oxford, 
 
277 UK. Mitonuclear protein imbalance (nDNA:mtDNA ratio) was determined by the 
 
278 ratio of nuclear encoded SDHB (Complex II) to mitochondrial-encoded MTCO1 
 
279 (Complex IV) as described previously [45]. 
 
 
 
280 Mitochondrial ROS production 
 
281 Fresh respiratory medium (MAS; 70 mM sucrose, 220 mM mannitol, 10 mM 
 
282 KH2PO4, 5 mM MgCl2, 2 mM HEPES, 1.0 mM EGTA and 0.2% (w/v) fatty acid-free 
 
283 BSA, pH 7.2) was supplemented with 1U/ml horseradish peroxidase and 10 uM 
 
284 Amplex® Red reagent (ThermoFisher Scientific, UK) as previously described [59]. 
 
285 90µl of this medium was then  added  to each  well of a  standard  96  well plate 
 286 (Costar®, Sigma Aldrich, UK) and heated for two min
-1  at 37°C. Fluorescence was 
 
287 then  measured  at  15  second  intervals  for  2-3  min  using  a  spectrophotometer 
 
288 (Clariostar microplate reader, BMG Labtech) at excitation and emission wavelength 
 
289 
 
290 
of 563 and 587nm respectively. A sequential protocol was then run simultaneously 
 
for  each  sample  in  triplicate  and  completed  within  15  min-1.  First  the  baseline 
 
291 fluorescence was measured by adding 10ul of mitochondrial suspension, and then 
 
292 mitochondrial hydrogen peroxide production from all complexes was determined by 
 
293 adding a saturating concentration of succinate (10mM), and then rotenone added 
 
294 (0.5uM; an inhibitor of complex I). The fluorescence signal was calibrated using 176 
 
295 nM of hydrogen peroxide, and then hydrogen peroxide production was calculated 
 
296 following background correction. 
 
 
297 Oxidative damage and antioxidant levels 
 
 
298 Protein carbonyl (PC), total glutathione (GSH) and total superoxide dismutase 
 
299 (SOD) activity were measured in liver samples using commercially available kits and 
 
300 following the manufacturer’s protocols (Catalogue#10005020  Carbonyl assay kit, 
 
301 #706002  Total  SOD  activity  assay  kit,  #703002  Glutathione  assay  kit,  Cayman 
 
302 Chemical  Company,  Estonia).  Hepatic  4-Hydroxynonenal  (HNE)-protein  adduct 
 
303 levels  were determined  using an  anti-HNE-His mouse  IgG protein  binding plate 
 
304 (Catalogue#STA-838, Cell Biolabs Inc., CA, USA). All assays were read on a plate 
 
305 reader (BMG Labtech, UK). 
 
 
306 Statistical Analysis 
 
 
307 All statistical analyses were performed using R and figures were produced 
 
308 using GraphPad Prism (GraphPad Inc., La Jolla, CA, USA, version 5) software. Data 
 
309 were  checked  for  normality  using  the  Shapiro–Wilks  test  and  a  logarithmic 
310 transformation was undertaken if data not normally distributed. Data was analysed 
 
311 using linear modelling (LM) with treatment (AL or DR) and strain (TejJ89, TejJ48 and 
 
312 TejJ114) introduced as fixed factors. Following transformation, if the data was not 
 
313 normally distributed an appropriate non-parametric test was applied. Results are 
 
314 reported as mean±standard  error of the mean  (SEM), with  p<0.05 regarded as 
 
315 
 
 
316 
statistically significant. 
317 3. Results 
 
 
318 Mitochondrial oxygen consumption rates (OCR) within isolated liver 
 
319 mitochondria under all conditions studied (Fig. 2A) were unaffected by 10 months of 
 
320 40% DR in strain TejJ89 relative to AL controls. A similar lack of a DR effect on 
 
321 hepatic respiratory capacities was observed in strain TejJ48 (Fig. 2B). In contrast, 
 
322 DR in strain TejJ114 (Fig. 2C) significantly reduced State 3 (t = 2.860, p = 0.006) and 
 
323 State 3u (t = 2.950, p=0.006) mitochondrial OCR relative to AL controls. While no 
 
324 differences in mitochondrial OCR were observed across ILSXISS strains under AL 
 
325 feeding  (Fig.  2D),  State  3  OCR  in  TejJ89  was  significantly  increased  (t=  2.24, 
 
326 p=0.039) relative to the other two strains under DR (Fig. 2E). 
 
 
327 Mitochondrial hydrogen peroxide (H2O2) production within liver was increased 
 
328 significantly (t=3.555, p=0.002) by DR in strain TejJ89 relative to its appropriate 
 
329 control, but DR had no effect on H2O2 production in strains TejJ48 and TejJ114 (Fig. 
 
330 3A). While no difference between strains in H2O2 production was observed under AL 
 
331 feeding (Fig. 3B), strain TejJ89 had significantly higher ROS levels compared to 
 
332 TejJ48 and TejJ114 under DR, and  TejJ48  had  significantly higher ROS levels 
 
333 (t=2.339, p=0.039) compared to TejJ114 (Fig. 3C). Total hepatic SOD activity was 
 
334 increased by DR treatment in strains TejJ89 (t = 3.776, p=0.004) and TejJ114 (t = 
 
335 2.845, p = 0.010) relative to their respective AL controls (Fig. 4A), but no strain- 
 
336 specific effect on SOD activity was observed under either AL or DR feeding (Fig. 
 
337 S2A & B). Liver total glutathione (Fig. 4B; Fig. S2C and D) and 4-HNE (Fig. 4C; Fig. 
 
338 S2E & F) were unaffected by either treatment or strain. However, hepatic protein 
 
339 carbonyl (PC) levels (Fig. 4D) were significantly increased in strains TejJ89 (t=2.420, 
 
340 p=0.037)  and  TejJ114  (t=2.440,  p=0.040)  under  DR  when  compared  to  their 
 
341 respective  AL  controls.  In  addition,  while  PC  levels  were  not  different  between 
342 strains under AL feeding (Fig. S2G), hepatic PC levels were significantly lower in 
 
343 TejJ48 compared to both TejJ89 (t=6.860, p<0.001) and TejJ114 (t=3.220, p=0.010) 
 
344 under DR (Fig. S2H). 
 
 
345 Total  hepatic protein levels  of  PGC-1α  (Fig.  5A),  a  key transcriptional  co- 
 
346 activator  linked  to  mitochondrial  metabolism  and  biogenesis,  was  unaltered  by 
 
347 treatment or strain, with both nuclear (Fig. 5B) and cytoplasmic (Fig. 5C) PGC-1α 
 
348 levels likewise unaffected. Similarly, mitochondrial transcription factor A (TFAM), a 
 
349 key activator of mitochondrial transcription, was unaffected by DR or strain (Fig. 5D). 
 
350 We then examined various OXPHOS complexes within liver, but again observed no 
 
351 treatment  effect  or  observed  any  differences  between  strains  under  AL  or  DR 
 
352 feeding (Figure S3A-C). Given the evidence of mitochondrial dysfunction in TejJ114, 
 
353 
 
354 
we then went on to investigate whether DR induced mitonuclear protein imbalance 
 
and UPRmt by firstly calculating the ratio of nuclear encoded SDHB to mitochondrially 
 
355 encoded MTCO1 as previously described [45]. We observed no effect of either 
 
356 treatment or strain on mitochondrial nuclear imbalance (Fig. 6A-C). No differences 
 
357 were  observed  between  either  treatment  groups  or  strains  in  the  mitochondrial 
 
358 chaperone HSP60 (Fig. 6D), but a significant reduction in hepatic HSP90 (Fig. 6E) 
 
359 was observed in strain TejJ114 under DR (t=2.267, p=0.045) relative to AL controls. 
 
 
360 In order to determine whether mitochondrial dysfunction in strain TejJ114 was 
 
361 specific to liver, we also examined a number of mitochondrial parameters in isolated 
 
362 skeletal muscle from these same mice. No treatment or strain-specific differences in 
 
363 mitochondrial OCR were observed (Fig. 7A-E). Skeletal muscle mitochondrial H2O2 
 
364 production significantly reduced under DR in strain TejJ114 (Mann Whitney p=0.009) 
 
365 (Fig. 9A) compared to AL controls, but unaffected by DR in the other two strains. No 
 
366 differences in mitochondrial H2O2 production was observed between strains under 
367 AL feeding (Fig. 9B), but was significantly reduced in TejJ114 under DR relative to 
 
368 TejJ89 (t=2.903, p=0.044) and TejJ48 (Mann Whitney p=0.009). Similar to liver, total 
 
369 and cytosolic PGC1α levels (Fig. 8A & B) were unaffected by DR in all strains, 
 
370 although nuclear PGC1α levels were increased in TejJ89 (t=3.174, p=0.034). Protein 
 
371 levels of  various OXPHOS complexes and  mitonuclear protein imbalance within 
 
372 skeletal muscle were unaffected by treatment and strain (Figure S3D-F; Fig. 10A), as 
 
373 was also the case in heart (Fig. S3G-I; Fig. 10B). 
374 4. Discussion 
 
 
375 The phenotypic plasticity of the mitochondria is crucial to allow energetic 
 
376 demands  to  be  met  and  in  order  to  sustain  bioenergetic  efficiency  [42],  [60]. 
 
377 Consequently  impairments  in  this  dynamic  system  can  lead  to  profound  health 
 
378 consequences, with mitochondrial dysfunction widely proposed as a hallmark of 
 
379 ageing [61], [62]. As discussed earlier, enhanced mitochondrial function has been 
 
380 put forward as a candidate mechanism underlying the beneficial effects of DR on 
 
381 lifespan  and  healthspan  [63],  [64].  Here  we  sought  to  investigate  mitochondrial 
 
382 function in using a comparative approach in ILSXISS mice which are known to show 
 
383 significant strain-specific variation in lifespan under 40% DR [15], [24]. 
 
 
384 Contrary to our initial predictions, 40% DR did not alter hepatic mitochondrial 
 
385 respiratory capacity in strain TejJ89, which is reported to show lifespan extension 
 
386 under DR. While several studies have reported that DR increases mitochondrial 
 
387 respiratory capacity in rodents [31]–[34], other studies have reported a DR-induced 
 
388 decrease [65], [35], [66], or no effect of DR on mitochondrial respiratory capacity 
 
389 [36], [67] relative to AL controls. The precise reasons for this ambiguity appears 
 
390 complex but  the  tissue  studied,  the  preparation  used  (isolated  mitochondria  vs. 
 
391 permeabilised tissue vs. tissue homegenate), the duration, age of onset and level of 
 
392 DR imposed, and the sex, age and the genetic background of the animal may all be 
 
393 important [31], [64], [68], [69]. Strain  TejJ48  under DR, as predicted, displayed 
 
394 essentially no mitochondrial phenotype relative to its AL control. However, in strain 
 
395 TejJ114, mitochondrial respiratory capacity associated with State 3 and State 3u 
 
396 (maximal uncoupled oxygen consumption rates) were significantly reduced under 
 
397 DR. Both ageing and many pathologies associated with ageing reduce mitochondrial 
 
398 respiratory capacities in a range of tissues [70], [71], and the apparent DR-induced 
399 hepatic mitochondrial dysfunction may offer new insights in to why DR truncates 
 
400 lifespan  in  this  particular  ILSXISS  strain.  To  determine  whether  the  hepatic 
 
401 mitochondrial dysfunction in TejJ114 was liver-specific, we determined mitochondrial 
 
402 respiratory capacity in isolated skeletal muscle mitochondria in these same ILSXISS 
 
403 mice  under  AL  and  DR  feeding.  Despite  DR  known  to  preserve  mitochondrial 
 
404 function during ageing in certain mouse strains, such as C57BL/6 and male B6D2F1 
 
405 [31], [34], we saw no effect of DR on skeletal muscle mitochondrial respiratory 
 
406 capacity in any strain. In view of the well-defined role of PGC1α in modulating 
 
407 mitochondrial function, and given that that mitochondrial adaptations to DR may be 
 
408 driven through a PGC1α-induced transcriptional program [39], [41], [64], [72], we 
 
409 investigated protein levels of PGC1α within liver in each strain under AL and DR. In 
 
410 line with the absence of any effect of DR on mitochondrial respiratory capacity, we 
 
411 observed no increase in hepatic PGC1α (total, cytosolic, nuclear) or in mitochondrial 
 
412 transcription factor A (TFAM) protein levels of strain TejJ89 under DR. Similarly, 
 
413 PGC-1α and TFAM levels were unaffected by DR in strains TejJ48 or TejJ114. 
 
414 However,  a  tissue-specific  response  was  observed  with  40%  DR  significantly 
 
415 increasing nuclear PGC1α within skeletal muscle of strain TejJ89, in line with what 
 
416 has been reported in other studies (for review see[64]). 
 
 
417 We then employed an immunoblot approach to examine respiratory chain 
 
418 complexes I, II, III, IV and V, and we again observed no treatment effect in any 
 
419 strains for liver, skeletal muscle or in heart. Indeed, it has been reported that DR- 
 
420 induced attenuation of ageing-associated declines in mitochondrial function within 
 
421 skeletal muscle appears to be independent of any effect on mitochondrial respiratory 
 
422 chain protein levels [34] However, this approach enabled us to examine mitonuclear 
 
423 protein imbalance; that is the ratio of nuclear encoded SDHB to mitochondrially 
424 
 
425 
encoded MTCO1. An increase in this ratio is associated with an induction in the 
 
cytoprotective mitochondrial unfolded protein response (UPRmt), a recently proposed 
 
426 conserved  lifespan  determinant  [45]. We  found  no  evidence  that  DR  increased 
 
427 
 
428 
mitonuclear protein imbalance within the liver, skeletal muscle or heart of ILSXISS 
 
mice under DR feeding. The UPRmt invokes a transcriptional program in response to 
 
429 a number of processes, including mitochondrial dysfunction, resulting in the induction 
 
430 of various chaperones and proteases that help facilitate mitochondrial proteostasis 
 
431 [73]. We therefore, then examined the molecular chaperones HSP60 and HSP90, 
 
432 and similarly showed a lack of any treatment effect across our strains, except for a 
 
433 significant reduction in HSP90 levels within liver of TejJ114 mice under DR. HSP90 
 
434 engages with a large number of ‘client’ proteins through co-chaperones, plays a 
 
435 major role in signal transduction, protects the 20S proteasome against oxidative 
 
436 inactivation and may actively regulate mitochondrial metabolism [74]–[76]. Whilst it is 
 
437 difficult to disentangle cause and effect here, our data indicates that in strain TejJ114 
 
438 40% DR leads to hepatic mitochondrial dysfunction and that this is correlated with 
 
439 reduced HSP90 levels. 
 
 
440 It is evident that both ageing and several disease states are associated with 
 
441 greater ROS-induced oxidative damage, but it is equivocal as to whether ROS- 
 
442 induced oxidative damage is the mechanism underpinning ageing and disease [30], 
 
443 [77], [78]. A large number of studies have investigated whether DR can reduce ROS, 
 
444 induce various antioxidants and attenuated oxidative damage in model organisms. In 
 
445 an  excellent  recent  meta-analysis,  the  Van  Remmen  laboratory  [30]  examined 
 
446 several hundred studies that have investigated the effect of DR in rodents on ROS 
 
447 production, various antioxidants and on oxidative damage. Their approach found that 
 
448 DR had remarkably little impact on ROS production or antioxidant activity overall, but 
449 53% of studies reported that DR reduced oxidative damage. Perhaps surprisingly we 
 
450 found that DR in strain TejJ89, which shows lifespan extension under 40% DR, had 
 
451 significantly higher hepatic mitochondrial H2O2 production, alongside greater hepatic 
 
452 total SOD activity and higher protein carbonyl levels relative to its appropriate AL 
 
453 control.  In  addition,  TejJ89  had  significantly  higher  hepatic  mitochondrial  H2O2 
 
454 production relative to the other two strains under DR feeding. Strain TejJ114 had 
 
455 increased hepatic total SOD activity and protein carbonyl levels relative to its AL 
 
456 controls, but mitochondrial ROS levels were not significantly altered. Similarly, the 
 
457 hepatic protein carbonyl levels in line TejJ114 under DR could not be explained by 
 
458 differences in hepatic NADPH oxidase  levels (Fig.  S4). The mitochondrial ROS 
 
459 profile in skeletal muscle was similar in skeletal muscle but H2O2  production was 
 
460 significantly reduced by DR in TejJ114 compared to its appropriate control and when 
 
461 compared to the other two strains under DR. Consequently, our findings further 
 
462 question the precise role of ROS-induced oxidative damage being the mechanism 
 
463 underpinning ageing. We can speculate that the increased ROS under DR in strain 
 
464 TejJ89 elicited a beneficial mitohormesis-like  effect [79] resulting in  DR-induced 
 
465 
 
466 
longevity, although this remains to be determined and does not appear to involve the 
 
UPRmt. As a small aside, it is particularly sobering to note that in the comprehensive 
 
467 meta-analysis on DR and oxidative stress in rodents undertaken by Walsh et al. [30], 
 
468 96%  of  all  observations  were  made  in  male  rodents,  with  the  remaining  4% 
 
469 undertaken using females alone or mixed sex populations. 
 
 
470 In conclusion, our findings do not completely support our initial predictions (Fig. 
 
471 1), in which we forecast a clear continuum from the stimulatory and beneficial effects 
 
472 of DR on the mitochondrial phenotype in positive responding strain TejJ89 through to 
 
473 predicted  mitochondrial  dysfunction  in  strain  TejJ114  under  DR.  In  the  positive 
474 responding  strain  TejJ89  we  saw  no  evidence  of  a  DR-induced  increase  in 
 
475 mitochondrial respiratory capacity in liver and muscle mitochondria or in PGC-1α 
 
476 levels  within  liver,  although  nuclear  PGC-1α  levels  were  induced  in  muscle. 
 
477 Paradoxically, TejJ89 had increased hepatic mitochondrial ROS production, greater 
 
478 SOD activity and higher hepatic protein carbonyl levels under DR, further highlighting 
 
479 the complexity between mitochondrial respiratory capacity, mitochondrial ROS and 
 
480 oxidative  damage  [80].  While  strain  TejJ114  under  DR  did  show  evidence  of 
 
481 mitochondrial dysfunction within liver relative to AL controls, this effect was tissue- 
 
482 specific as was not observed in skeletal muscle. What is clear is that it will now be 
 
483 important to investigate whether the liver-specific mitochondrial dysfunction observed 
 
484 in strain TejJ114 under 40% DR is evident under less restrictive feedings conditions, 
 
485 i.e. 10-30% DR, as for all these strains we do not currently know where exactly the 
 
486 optimal longevity ‘sweet-spot’ for these lines under DR sits. Our data also raises the 
 
487 
 
488 
possibility that DR-induced longevity in ILSXISS mice does not appear to involve 
 
mitonuclear imbalance and UPRmt, which also appears to be the case in worm DR 
 
489 (eat-2) mutants [81]. What is also clear is that almost all we know about the potential 
 
490 mechanisms underlying DR in rodents is based almost exclusively on C57BL/6 mice 
 
491 [19]. Consequently, there is a need for more studies using mouse strains in addition 
 
492 to  C57BL/6  mice,  e.g.  ILSXISS,  DBA/2,  UM-HET3,  as  these  models  may  help 
 
493 provide new insights in to ageing mechanisms that are public, i.e. shared, across all 
 
494 mouse strains rather than mechanisms that are private, i.e. specific to C57BL/6 
 
495 
 
 
496 
mice. 
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504 Figure legends 
 
 
505 Figure 1: Schematic showing the predicted mitochondrial functional response to 10 
 
506 months of 40% dietary restriction (DR) in three strains of female ILSXISS mice that 
 
507 show a differential response of DR on longevity (TejJ89 lifespan extension; TejJ48 
 
508 no change in lifespan; TejJ114 lifespan shortening). 
 
 
509 Figure 2: Mitochondrial respiration (Oxygen consumption rate, OCR) was unaltered 
 
510 by 10 months of 40% DR in isolated liver mitochondria from strains TejJ89 (A) and 
 
511 TejJ48 (B). In strain TejJ114 (C), a significant treatment effect was observed with 
 
512 State 3 and State 3u OCR significantly reduced under DR relative to AL mice. No 
 
513 strain differences on mitochondrial functional was observed in AL mice (D). (E) State 
 
514 3 respiratory capacity was significantly increased in strain TejJ89 under DR when 
 
515 compared with the other strains under DR. Values are expressed as mean ± SEM, 
 
516 with n = 8 per group. * denotes p<0.05. 
 
 
517 Figure 3: Hydrogen peroxide (H2O2) production within isolated liver mitochondria, 
 
518 expressed as fold change relative to respective AL controls. (A) H2O2 production was 
 
519 increased by DR only in strain TejJ89. H2O2  production was unaltered between 
 
520 strains under AL feeding (B), but under DR H2O2  production was elevated in strain 
 
521 TejJ89 compared to both TejJ48 and TejJ114, and strain TejJ48 produced more 
 
522 H2O2 than TejJ114. Values are expressed as mean ± SEM, with n = 6 per group. ** 
 
523 p<0.001, * p<0.05. 
 
 
524 Figure 4: Hepatic antioxidant defence and oxidative damage markers. (A) Total 
 
525 SOD activity was significantly increased by DR in strains TejJ89 and TejJ114 relative 
 
526 to their respective AL controls. (B) Total glutathione (GSH) and (C) 4- 
 
527 Hydroxynonenal (HNE) levels were unaffected by treatment or strain. (D) Protein 
528 carbonyl  (PC)  levels  were  significantly  increased  by  DR  in  strains  TejJ89  and 
 
529 TejJ114 relative to AL controls. Values are expressed as mean ± SEM, where n= 6 
 
530 per group. ** p<0.001, * p<0.05. 
 
 
531 Figure 5: Total (A), nuclear (B), and cytosolic (C) hepatic PGC-1α protein levels. No 
 
532 treatment or strain differences in hepatic PGC-1α protein levels were observed (D) 
 
533 DR or strain similarly had no effect on hepatic TFAM levels. Values are expressed as 
 
534 arbitrary units (AU) relative to total protein (determined by Ponceau staining). All 
 
535 values are expressed as means ± SEM, where n = 6 per group. 
 
 
536 Figure 6: Hepatic mitonuclear protein imbalance, expressed as the ratio between the 
 
537 nuclear DNA (SDHB) relative to mitochondrial DNA (MTCO1). (A-C) Mitochondrial 
 
538 protein imbalance was unaffected by treatment or strain. No treatment or strain 
 
539 effects were detected in HSP60 levels, however hepatic HSP90 was significantly 
 
540 reduced by DR in strain TejJ114 compared to its AL counterpart. No differences in 
 
541 HSP90 levels were observed between strains within the AL or DR treatment groups. 
 
542 Values are expressed as arbitrary units (AU) relative to total protein (determined by 
 
543 Ponceau staining). All values are expressed as means ± SEM, where n = 6 per 
 
544 group. * p< 0.05 
 
 
545 Figure 7: Mitochondrial respiration (Oxygen consumption rate, OCR) in isolated 
 
546 skeletal muscle mitochondria was unaltered by 10 months of 40% DR in all strains (A 
 
547 –C). Similarly no differences were observed between strains within the AL (D) or DR 
 
548 groups (E). Values are expressed as mean ± SEM, with n = 8 per group 
 
 
549 Figure 8: Total (A), nuclear (B), and cytosolic (C) PGC-1α protein levels in skeletal 
 
550 muscle. No differences in PGC-1α protein levels were observed by treatment in total 
 
551 (A) or cytosolic (C) skeletal muscle fractions. An increase in PGC-1α was observed 
552 in nuclear PGC-1α protein fraction with DR (B). Strain was not found to alter PGC-1α 
 
553 levels in total, nuclear or cytosolic proteins within either the AL or DR treatment 
 
554 group. Values are expressed as arbitrary units (AU) relative to total protein 
 
555 (determined by Ponceau staining). All values are expressed as means ± SEM, where 
 
556 n = 6 per group. * p< 0.05 
 
 
557 Figure  9:  Skeletal  muscle  mitochondrial  hydrogen  peroxide  (H2O2)  production, 
 
558 expressed as fold change relative to respective AL controls. (A) H2O2 production was 
 
559 significantly decreased by DR in strain TejJ114. H2O2  production was unaltered 
 
560 between strains under AL feeding (B), but under DR feeding H2O2  production was 
 
561 reduced in strain TejJ114 relative to the other two strains. Values are expressed as 
 
562 mean ± SEM, with n = 6 per group. ** p<0.001, * p<0.05. 
 
 
563 Figure 10: Mitonuclear protein imbalance in gastrocnemius (A) and heart (B), 
 
564 expressed as the ratio between the nuclear DNA (SDHB) relative to mitochondrial 
 
565 DNA (MTCO1). No treatment or strains effects were detected. Values are expressed 
 
566 as arbitrary units (AU) relative to total protein (determined by Ponceau staining). All 
 
567 values are expressed as means ± SEM, where n = 6 per group. 
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